Central Nervous System as Possible Site of Relapse in ERBB2-Positive Metastatic Colorectal Cancer: Long-term Results of Treatment With Trastuzumab and Lapatinib.

Andrea Sartore-Bianchi, Sara Lonardi, Massimo Aglietta, Cosimo Martino, Fortunato Ciardiello, Silvia Marsoni, Salvatore Siena

Research output: Contribution to journalArticlepeer-review

Original languageUndefined/Unknown
Pages (from-to)927-929
Number of pages3
JournalJAMA oncology
Volume6
DOIs
Publication statusPublished - Jun 1 2020

Keywords

  • Adult
  • Aged
  • 80 and over
  • Antineoplastic Agents
  • therapeutic use
  • Central Nervous System Neoplasms
  • radiotherapy
  • secondary
  • surgery
  • Colorectal Neoplasms
  • drug therapy
  • metabolism
  • mortality
  • pathology
  • Drug Resistance
  • Neoplasm
  • Female
  • Humans
  • Lapatinib
  • Male
  • Middle Aged
  • Protein Kinase Inhibitors
  • Receptor
  • ErbB-2
  • Recurrence
  • Trastuzumab
  • Treatment Outcome

Cite this